Impact of Locally Administered Carboxydextran‐Coated Super‐Paramagnetic Iron Nanoparticles on Cellular Immune Function
Source abstract
Abstract
Abstract Interstitially administered iron oxide particles are currently used for interoperative localization of sentinel lymph nodes (LNs) in cancer staging. Several studies have described concerns regarding the cellular accumulation of iron oxide nanoparticles relating them to phenotype and function deregulation of macrophages, impairing their ability to mount an appropriate immune response once an insult is present. This study aims to address what phenotypic and functional changes occur during lymphatic transit and accumulation of these particles. Data show that 60 nm carboxydextran‐coated iron nanoparticles use a noncellular mechanism to reach the draining LNs and that their accumulation in macrophages induces transient phenotypic and functional changes. Nevertheless, macrophages recover their baseline levels of response within 7 days, and are still able to mount an appropriate response to bacterially induced inflammation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Barrier Structure and Function Studies · Immune cells in cancer
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
MRC Cancer Unit University of Cambridge Hutchison/MRC Research Centre Box 197, Cambridge Biomedical Campus Cambridge CB2 0XZ UK
Endomagnetics Ltd. The Jeffreys Building St John's Innovation Park, Cowley Road Cambridge CB4 0WS UK
Funding
Medical Research Council
References (52)
Show source-provided references
1. 10.1088/0022-3727/42/22/22400110.1088/0022-3727/42/22/224001 ↗
2. 10.1007/s11427-017-9271-110.1007/s11427-017-9271-1 ↗
3. 10.1007/s11095-016-1958-510.1007/s11095-016-1958-5 ↗
4. 10.1002/btm2.1000310.1002/btm2.10003 ↗
5. 10.2967/jnumed.116.18136210.2967/jnumed.116.181362 ↗
6. Ventola C. L. · P T. · 2017 · 42 · 742
7. 10.1148/radiol.201716275910.1148/radiol.2017162759 ↗
8. 10.21037/qims.2017.02.0910.21037/qims.2017.02.09 ↗
9. 10.1259/bjr.2015063410.1259/bjr.20150634 ↗
10. 10.1007/s10549-016-3809-910.1007/s10549-016-3809-9 ↗
11. 10.1245/s10434-013-3379-610.1245/s10434-013-3379-6 ↗
12. 10.1007/s10549-013-2657-010.1007/s10549-013-2657-0 ↗
13. 10.1111/his.1201910.1111/his.12019 ↗
14. 10.1245/s10434-016-5135-110.1245/s10434-016-5135-1 ↗
15. 10.2214/ajr.152.1.16710.2214/ajr.152.1.167 ↗
16. 10.1016/j.jamcollsurg.2011.11.00610.1016/j.jamcollsurg.2011.11.006 ↗
17. 10.1002/eji.20073798410.1002/eji.200737984 ↗
18. 10.1152/japplphysiol.00389.200610.1152/japplphysiol.00389.2006 ↗
19. 10.1016/S0005-2736(97)00122-310.1016/S0005-2736(97)00122-3 ↗
20. 10.1016/S0169-409X(01)00154-510.1016/S0169-409X(01)00154-5 ↗
21. 10.1016/j.jconrel.2006.01.00610.1016/j.jconrel.2006.01.006 ↗
22. 10.1158/0008-5472.CAN-10-027110.1158/0008-5472.CAN-10-0271 ↗
23. 10.1021/nn203124x10.1021/nn203124x ↗
24. 10.1371/journal.pone.000329010.1371/journal.pone.0003290 ↗
25. 10.1016/S1074-7613(00)80149-110.1016/S1074-7613(00)80149-1 ↗
26. 10.1038/ni.208510.1038/ni.2085 ↗
27. 10.1016/j.it.2012.02.00710.1016/j.it.2012.02.007 ↗
28. 10.1016/S0167-5699(98)01427-310.1016/S0167-5699(98)01427-3 ↗
29. Sato K. · J. Immunol. · 1998 · 161 · 683510.4049/jimmunol.161.12.6835 ↗
30. 10.1182/blood-2009-12-25990310.1182/blood-2009-12-259903 ↗
31. 10.1146/annurev.immunol.26.021607.09025410.1146/annurev.immunol.26.021607.090254 ↗
32. 10.1016/j.it.2010.10.00410.1016/j.it.2010.10.004 ↗
33. 10.1084/jem.192.10.142510.1084/jem.192.10.1425 ↗
34. 10.1016/j.immuni.2004.11.01310.1016/j.immuni.2004.11.013 ↗
35. 10.1007/s00018-009-0053-z10.1007/s00018-009-0053-z ↗
36. 10.1021/nn200075610.1021/nn2000756 ↗
37. 10.1021/nn402145t10.1021/nn402145t ↗
38. 10.1002/mrm.2229010.1002/mrm.22290 ↗
39. 10.2147/IJN.S13810810.2147/IJN.S138108 ↗
40. 10.1038/nnano.2016.16810.1038/nnano.2016.168 ↗
41. 10.1016/j.nano.2015.11.02010.1016/j.nano.2015.11.020 ↗
42. 10.1021/jp502622410.1021/jp5026224 ↗
43. 10.1039/C5RA18810E10.1039/C5RA18810E ↗
44. 10.1016/j.bbrc.2013.10.11510.1016/j.bbrc.2013.10.115 ↗
45. 10.1016/j.biomaterials.2010.08.00310.1016/j.biomaterials.2010.08.003 ↗
46. 10.1016/j.biomaterials.2016.09.03410.1016/j.biomaterials.2016.09.034 ↗
47. 10.1084/jem.2017160810.1084/jem.20171608 ↗
48. 10.1016/j.immuni.2013.04.00410.1016/j.immuni.2013.04.004 ↗
49. 10.1038/ni137510.1038/ni1375 ↗
50. 10.1038/ni137610.1038/ni1376 ↗
51. 10.4049/jimmunol.090056810.4049/jimmunol.0900568 ↗
52. 10.1016/S1499-3872(14)60024-210.1016/S1499-3872(14)60024-2 ↗